Scientists probe immune health in BRCA carriers using flu shot
NCT ID NCT04499534
Summary
This study aims to understand how BRCA1 or BRCA2 gene mutations affect the immune system's response to the seasonal flu vaccine. Researchers are enrolling 50 healthy adults with these mutations but no cancer history to measure their antibody levels before and after vaccination. The goal is to learn whether these genetic changes impact overall immune health and vaccine effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRCA1 MUTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.